AptarGroup, a company based outside of Chicago, Illinois, has announced that the FDA recently approved a medication (NAYZILAM (midazolam)) for treatment of acute repetitive epileptic seizures and that the company’s Unidose Liquid System was chosen as the delivery mechanism for this rescue drug.
The Unidose Liquid System doesn’t (Read more...)